The Alzheimer’s Disease Metabolomics Consortium (ADMC), led by Dr. Kaddurah-Daouk based at Duke University,  has assembled a diverse group of researchers with different backgrounds across many academic institutions.  This team is working closely and collaboratively within the consortium and across the AMP-AD, MODEL-AD, and MOVE-AD consortia to maximize knowledge gained from metabolomic profiling of large cohorts. Included are centers of excellence in metabolomics, informatics, modeling, clinical, imaging, and genetics.

Click on slide for a more legible view.

Group Acknowledgement

Different journals request that acknowledgements be submitted in a particular format. Below is an example for the Journal of Neurology’s criteria.

• Contributors who do not meet the criteria for Authorship must be listed in the Acknowledgment section that includes each person’s affiliation and contributions.
• Neurology will not publish links to Web sites listing Coinvestigators or Contributors. The Corresponding Author must supply the information formatted as below and include name, degree(s), and, in parentheses, location and role:

Alzheimer’s Disease Metabolomics Consortium (ADMC) and Alzheimer Gut Microbiome Project (AGMP) Members

Rima Kaddurah-Daouk, Ph.D. (Duke University, Principal Investigator); Alexandra Kueider-Paisley, Ph.D. (Duke University); P. Murali Doraiswamy, M.B.B.S. (Duke University); Colette Blach, M.S. (Duke University); Arthur Moseley, Ph.D. (Duke University; PI); Siamak Mahmoudiandehkhordi, Ph.D. (Duke University ); Kathleen Welsh-Balmer, Ph.D. (Duke University ); Brenda Plassman, Ph.D. (Duke University ); Andrew Saykin, Psy.D. (Indiana University School of Medicine, PI); Kwangsik Nho, Ph.D. (Indiana University School of Medicine; Co-I); Shannon Risacher, Ph.D. (Indiana University School of Medicine); Gabi Kastenmüller, Ph.D. (Helmholtz Zentrum München, PI); Matthias Arnold, Ph.D. (Helmholtz Zentrum München, Co-I); Xianlin Han, Ph.D. (University of Texas Health Science Center San Antonio); Rebecca Baillie, Ph.D. (Rosa & Co., LLC); Rob Knight, Ph.D. (University of California – San Diego, PI); Pieter Dorrestein, Ph.D. (University of California – San Diego); James Brewer (University of California – San Diego); Emeran Mayer, M.D. (University of California – Los Angeles, PI); Jennifer Labus (University of California – Los Angeles); Pierre Baldi, Ph.D. (University of California – Los Angeles); Arpana Gupta, Ph.D. (University of California – Los Angeles); Oliver Fiehn, Ph.D. (West Coast Metabolomics Center – University of California- Davis); Dinesh Barupal, Ph.D. (Icahn School of Medicine at Mount Sinai); Peter Meikle, Ph.D. (Baker Heart and Diabetes Institute, PI); Sarkis Mazmanian, Ph.D. (California Institute of Technology, PI); Dan Rader, Ph.D. (University of Pennsylvania, PI); Leslie Shaw, Ph.D. (University of Pennsylvania); Cornelia van Duijin, Ph.D. (Oxford University, PI); Najaf Amin (Oxford University); Alejo Nevado-Holgado, Ph.D. (Oxford University); David Bennett, M.D. (Rush University); Ranga Krishnan, M.D. (Rush University); Ali Keshavarzian, Ph.D. (Rush University); Robin Vogt, Ph.D. (Rush University); Arfan Ikram, M.D., Ph.D. (Erasmus MC, PI); Thomas Hankemeier, Ph.D. (Leiden University Metabolomics Center, PI); Ines Thiele, Ph.D. (National University of Ireland – Galway, PI); Cory Funk, Ph.D. (Institute for Systems Biology); Priyanka Baloni, Ph.D. (Purdue University); Wei Jia, Ph.D. (University of Hawaii Cancer Center); David Wishart, Ph.D. (The Metabolomics Innovation Centre Canada, PI); Roberta Brinton, Ph.D. (University of Arizona, PI); Lindsay Farrer, Ph.D. (Boston University, PI); Rhoda Au, Ph.D. (Boston University); Wendy Qiu, M.D., Ph.D. (Boston University); Peter Würtz, Ph.D. (Nightingale Health); Therese Koal, Ph.D. (Biocrates Life Sciences AG); Anna Greenwood, Ph.D. (Sage Bionetworks); Jan Krumsiek, Ph.D. (Weill Medical College of Cornell, Co-I); Karsten Suhre, Ph.D. (Weill Medical College of Cornell); John Newman, Ph.D. (USDA ARS); Ivan Hernandez, M.D. (SUNY Downstate, PI); Tatania Foroud, Ph.D. (National Centralized Repository for Alzheimer’s and other Dementias, PI); Frank Sacks, M.D. (Harvard School of Public Health);